EastPharma Ltd. reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenue of USD 210,532,767 compared to USD 217,125,087 reported a year ago. Loss before tax was USD 1,957,883 compared to profit before tax of USD 1,516,263 reported a year ago.

Net loss attributable to equity holders of the parent was USD 1,617,948 or USD 0.02 per basic and diluted share compared to USD 529,423 or USD 0.01 per basic and diluted share reported a year ago. Net cash provided by operating activities was USD 18,332,555 compared to USD 30,055,342 reported a year ago. Purchase of property, plant and equipment was USD 15,026,168 compared to USD 26,777,437 reported a year ago.

Purchase of intangible assets was USD 19,379,687 compared to USD 15,675,378 reported a year ago.